Zymfentra (Infliximab-dyyb): Uses, Side Effects & Interactions
1. Introduction & Mechanism of Action of Zymfentra Zymfentra is a highly advanced biological therapy representing the first FDA-approved subcutaneous formulation of infliximab-dyyb designed specifically for the continuous maintenance treatment of severe inflammatory bowel disease. The most notable side effect is profound systemic immunosuppression leading to a drastically heightened susceptibility to serious opportunistic infections. Infliximab-dyyb … Read more